Victoza (liraglutide), Byetta (exenatide), Bydureon (extended-release exenatide), and Trulicity (dulaglutide) are no longer eligible for weight loss coverage under many Anthem plans
136,169,170 With the accumulation of more clinical data and the development of new drugs, these treatment options are expected to provide more effective and comprehensive treatment choices for diabetes patients
So were trying to figure out how employers can get something along those lines. CEO, health benefits organization We were talking to a Canadian advisor
Also, widespread awareness among both clinicians and patients drives the expansion
DPP4i relies on endogenous GLP-1 to be effective, while GLP-1-RA does not
The medication already slows how quickly food leaves your stomach dramatically increasing fiber all at once can intensify GI side effects